4. Heartburn Medications
Proton pump inhibitors (PPIs) such as omeprazole, lansoprazole, pantoprazole, rabeprazole, and esomeprazole are commonly used to treat acid reflux and heartburn. While generally safe, long-term or high-dose use has been linked to an increased risk of acute interstitial nephritis, a form of kidney inflammation that can progress to chronic kidney disease if unrecognized.
This risk is particularly relevant for patients self-medicating or using PPIs beyond recommended durations without medical supervision. Kidney damage from PPIs may present with nonspecific symptoms such as fatigue, swelling, or changes in urine output, making routine laboratory monitoring important in high-risk individuals.
- Use the lowest effective dose for the shortest duration possible.
- Inform your healthcare provider about any prolonged PPI use.
- Periodic kidney function tests should be considered during chronic therapy.
Consult your doctor before starting or stopping PPIs, especially if you have existing kidney disease or other risk factors.
5. Antiviral Drugs
Antiviral medications such as acyclovir, used for herpes infections, and protease inhibitors like indinavir and tenofovir for HIV treatment, carry a risk of nephrotoxicity. These drugs can cause crystal nephropathy, acute tubular necrosis, or interstitial nephritis, leading to impaired renal function.
Kidney damage may manifest as elevated serum creatinine, reduced glomerular filtration rate (GFR), or electrolyte imbalances. Hydration before and during antiviral therapy helps reduce the risk of crystal formation in the kidneys.
- Maintain adequate hydration during antiviral treatment.
- Regular monitoring of kidney function is essential, especially in patients with preexisting kidney issues.
- Report symptoms such as decreased urine output or swelling promptly.
Clinicians must weigh antiviral benefits against nephrotoxicity risks, adjusting doses based on kidney function tests.
6. Captopril
Captopril is an angiotensin-converting enzyme (ACE) inhibitor widely prescribed for hypertension and heart failure. While generally protective of kidney function in chronic kidney disease, captopril can sometimes cause acute kidney injury, especially in patients with bilateral renal artery stenosis or volume depletion.
The mechanism involves reduced glomerular filtration pressure due to vasodilation of the efferent arteriole in the kidney. This effect, while beneficial in many contexts, can lead to a sudden decline in kidney function in susceptible individuals.
- Baseline kidney function testing before initiating therapy is important.
- Monitor serum creatinine and potassium levels within 1-2 weeks of starting captopril.
- Avoid use in patients with bilateral renal artery stenosis or severe volume depletion.
Patients should report symptoms such as dizziness, decreased urine output, or swelling to their healthcare provider immediately. Dose adjustments or alternative medications may be necessary depending on kidney function changes.
